Search Browse Earnings

TherapeuticsMD, Inc.

Nasdaq:TXMD

Pharmaceutical Preparations·BOCA RATON, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.6M

-94.8% YoY

FY 2022

Adj. EBITDA

-$8.5M

-329.1% margin

FY 2024

Net Income

-$10.3M

-399.5% margin

FY 2024

EPS (Diluted)

-$0.99

FY 2024

Stock Price

$2.30

+1.8%

2026-03-09

52W Range

$0.72 – $2.95

P/E Ratio

-2.3x

Market Cap

$26.6M

Cash

$4.3M

FY 2024

Total Debt

—

Net Cash

$4.3M

FY 2022

Enterprise Value

$22.3M

Debt / EBITDA

0.5x

FY 2022

EV / EBITDA

-2.6x

Employees

—